21+ search results for 'Newswire'.

BioVaxys Announces Double Haptenized Vaccine. Trial Production of Vaccine Successful

2022-12-05: https: www.cphi.cn. 2022-12-05. 16: 49. Source: PR Newswire. Author: BioVaxys BioVaxys Technologies Inc. (CSE: .BIOV) (FRA: 5LB) (OTCQB: BVAXF) (hereinafter referred to as "BioVaxys" or the "Company") is pleased to announce the successful completion of sterilization and sterile trial production of  

 
CPHI 1 month ago 1 minute read

 
Xuzhenda Bio once again obtained the international certification of ISO15189 medical laboratory quality and capability requirements with zero defects

2022-12-06: https: www.cphi.cn. 2022-12-06. 13: 14. Source: PR Newswire. Author: Shanghai Supyida Biotechnology Co., Ltd. Recently, Survival Biotech Laboratory once again passed the ISO15189 medical laboratory quality and competency requirements international certification issued by the American Association  

 
CPHI 1 month ago 1 minute read

 
It's snowing today! Ruixue is coming, everything is hidden in winter, and the midwinter season begins-PR Newswire APAC

2022-12-07: Beijing Daily client. Cao Yu. Journalist. Luo Jing. Mei editor. Yuan Li On December 7, the third term of winter - heavy snow - began. Heavy snow marks the official start of the mid-winter season, when temperatures drop significantly, precipitation increases, and there will be significant cooling in northern

 
TOUTIAO 1 month ago 1 minute read

 
Viva Biotech's investment incubation company Focus-X has successfully reached an acquisition agreement with Fulian Medicine

2022-12-05: https: www.cphi.cn. 2022-12-05. 16: 39. Source: PR Newswire. Author: ViaBio Focus-X Therapeutics ("Focus-X"), a nuclide drug company incubated by VivaBio, successfully entered into an acquisition agreement with Radialink Pharmaceutical Technology Co., Ltd. ("Radialink"). Focus-X Therapeutics ("Focus-X"),  

 
CPHI 1 month ago 1 minute read

 
Lianhua's "Qingwen" or not "Qingwen" Yiling Pharmaceutical has the final say-PR Newswire APAC

2022-12-06: On November 15, the topic of selling out even Hua Qing Zirconium capsules hit the hot search. When consumers are still waiting to see if they want to stock up, some "eye red" manufacturers have found new business opportunities, staged a "true and false beauty monkey king." Even flowers, chain flowers,  

 
TOUTIAO 1 month ago 1 minute read

 
Authoritative Interpretation: Omicron Mutant Strain Causes Pneumonia or Severe Disease Rate Lower Than Influenza-PR Newswire APAC

2022-12-05: According to CCTV news, recently, the topic of weakening the pathogenicity of the Omicron mutant strain has received widespread attention. The joint prevention and control mechanism of the State Council invited Tong Zhaohui, an expert in critical respiratory diseases and director of Beijing Institute

 
TOUTIAO 1 month ago 1 minute read

 
Lingyue Technology received Zheng Jie, the Mayor of Yuhuatai District Government of Nanjing City, for a survey and visit


MSCBSC 1 month ago 1 minute read

 
Menarini unveils latest results at SABCS 2022

2022-12-05: https: www.cphi.cn. 2022-12-05. 17: 19. Source: PR Newswire. Author: Menarini. Group Menarini Group and Stemline, a wholly owned subsidiary of Menarini Group. Therapeutics will present additional data from the experimental oral SERD drug Elacestrant Phase 3 EMERALD Study (NCT03778931) at the San  

 
CPHI 1 month ago 1 minute read

 
The prevention and control plan of the new coronavirus infectious disease of the Infectious Diseases Branch of the China Association of Chinese Medicine is here-PR Newswire APAC

2022-12-07: Beijing Daily client. Yao. Journalist. Bai Bo The COVID-19 pandemic has had a huge impact on human health and socio-economic development. At present, the Omicron mutant strain is mainly prevalent, its toxicity is reduced, but more contagious, resulting in an increase in the number of people with the  

 
TOUTIAO 1 month ago 4 minutes read

 
Academician Wu Zhaohui Appointed Vice Minister of Science and Technology, Stepping Down as President of Zhejiang University-PR Newswire APAC

2022-12-05: Wu Chaohui On December 5, the website of the Ministry of Human Resources and Social Affairs announced the appointment and dismissal of state staff by Among them, Wu was appointed vice minister of science and technology, removing Wu from his post as president of Zhejiang University. According to public

 
TOUTIAO 1 month ago 1 minute read

 
Experts in Chongqing and Guangzhou analyzed the local epidemic situation, and both mentioned that the virulence of Omicron was significantly weakened-PR Newswire APAC

2022-12-06: Citizens outside Zhengjia Plaza Shopping Center, Guangzhou, Guangdong Province, December 3, 2022. At present, Guangzhou all walks of life orderly resumption of work, Guangzhou Tianhe business circle passenger flow orderly recovery. Recently, the topic of the toxicity of the Omicron mutant strain of

 
TOUTIAO 1 month ago 1 minute read

 
Will there be a medical run? Hierarchical diagnosis and treatment plans need to be established, when to see a doctor and science popularization should be timely-PR Newswire APAC

2022-12-07: Produced by Sohu Health Author. Yu. Wu Shiyan Editorial.. Recently, several provinces and cities have adjusted the prevention and control measures of the COVID-19 epidemic, and the ninth edition of the prevention and control plan and 20 optimization measures have been implemented Among them, Hangzhou,  

 
TOUTIAO 1 month ago 2 minutes read

 
The price of Lianhua Qingwen and ibuprofen is several times higher than that of the hospital, and the regulatory authorities in many places have issued warnings-PR Newswire APAC

2022-12-07: China Times (www.chinatimes.net.cn) journalist. Guo Yilin. Yu Na. Beijing reporting Recently, around the "four types of drugs" purchase policy adjustment, the country blew a tide of "medicine." In the face of the price rise brought by "antimony medicine," many regulators have issued a warning. Many

 
TOUTIAO 1 month ago 3 minutes read

 
Imjudo combined with Infineon in the first-line treatment of unresectable liver cancer has demonstrated significant survival benefits in Hong Kong and Taiwan populations

2022-12-07: https: www.cphi.cn. 2022-12-07. 11: 20. Source: PR Newswire. Author: AstraZeneca AstraZeneca's Imjudo (generic name: tremelimumab) and Infifan (generic name: devalioximab) first-line treatment of non-resectable liver cancer in the Phase I clinical study HIMALAYA was officially announced on December  

 
CPHI 1 month ago 2 minutes read

 
Questions and answers on the interpretation of the "Notice on Further Optimizing and Implementing the Prevention and Control Measures of the New Coronary Pneumonia Epidemic"-PR Newswire APAC

2022-12-07: Source: National Health Commission I. What is the background of the notice? What is the main content? Since the outbreak of the new coronavirus outbreak, the Party Central Committee and the State Council have always put people's life safety and health first. According to the characteristics of virus  

 
TOUTIAO 1 month ago 3 minutes read

 
Nucleic acid testing in many places bid farewell to normalization: listed companies' accounts receivable surged, and more energy was devoted to routine business-PR Newswire APAC

2022-12-06: Normalized nucleic acids are saying goodbye. In recent days, China has made many adjustments to the prevention and control measures of the new coronavirus epidemic, including arrangements for nucleic acid testing, since most no longer check the negative proof of nucleic acid testing, "non-necessary  

 
TOUTIAO 1 month ago 1 minute read

 
Talents and equipment moved to the United States, and their own operations cannot be the masters. TSMC’s establishment of a factory in the United States has caused multiple doubts-PR Newswire APAC

2022-12-07: Source: Global Times [Global Times Special correspondent. Zhang Ruo] TSMC's plant in Phoenix, Arizona, USA, ushered in a relocation ceremony on the 6th, with key figures including US President Joe Biden attending. TSMC's opening in the United States is also believed to be the intention of the United

 
TOUTIAO 1 month ago 1 minute read

 
Kintor Pharmaceutical's Phase II Clinical Trial of Freetaxen in the Treatment of Female Hair Loss Achieves the Primary Endpoint

2022-12-05: https: www.cphi.cn. 2022-12-05. 14: 49. Source: PR Newswire. Author: Pioneer Pharmaceuticals On December 1, 2022, Beijing time, Kaituo Pharmaceutical (stock code: 9939.HK) announced the main results of its independent research and development and potential first-of-its-kind clinical trial in China  

 
CPHI 1 month ago 1 minute read

 
Making a fortune for the country? A net profit of 100 million a year! Nucleic acid gross profit is as high as 95.43 percent, how to end nucleic acid profiteering-PR Newswire APAC

2022-12-06: Marx's theory of capital says that when profits exceed 50 percent, it is enough to make capitalists crazy, let alone more than 300 percent How crazy is the profit of nucleic acid testing? According to A-share listed companies have released third-quarter results, in the nucleic acid testing concept stock,

 
TOUTIAO 1 month ago 1 minute read

 
"Qingke Bio" received another 400 million yuan in B-round financing, accelerating the layout of the "gene factory" construction

2022-12-06: https: www.cphi.cn. 2022-12-06. 13: 07. Source: PR Newswire. Author: Beijing Qinke Biotechnology Co., Ltd. Recently, as a powerful gene synthesis enterprise in China, Beijing Qinke Biotechnology Co., Ltd. (hereinafter referred to as "Qinke Biotech") received another 400 million yuan Recently, as  

 
CPHI 1 month ago 2 minutes read

 

Load More

What China Reads


21+ search results for 'Newswire'.

BioVaxys Announces Double Haptenized Vaccine. Trial Production of Vaccine Successful

2022-12-05: https: www.cphi.cn. 2022-12-05. 16: 49. Source: PR Newswire. Author: BioVaxys BioVaxys Technologies Inc. (CSE: .BIOV) (FRA: 5LB) (OTCQB: BVAXF) (hereinafter referred to as "BioVaxys" or the "Company") is pleased to announce the successful completion of sterilization and sterile trial production of  


CPHI 1 month ago 1 minute read

 

Xuzhenda Bio once again obtained the international certification of ISO15189 medical laboratory quality and capability requirements with zero defects

2022-12-06: https: www.cphi.cn. 2022-12-06. 13: 14. Source: PR Newswire. Author: Shanghai Supyida Biotechnology Co., Ltd. Recently, Survival Biotech Laboratory once again passed the ISO15189 medical laboratory quality and competency requirements international certification issued by the American Association  


CPHI 1 month ago 1 minute read

 

It's snowing today! Ruixue is coming, everything is hidden in winter, and the midwinter season begins-PR Newswire APAC

2022-12-07: Beijing Daily client. Cao Yu. Journalist. Luo Jing. Mei editor. Yuan Li On December 7, the third term of winter - heavy snow - began. Heavy snow marks the official start of the mid-winter season, when temperatures drop significantly, precipitation increases, and there will be significant cooling in northern


TOUTIAO 1 month ago 1 minute read

 

Viva Biotech's investment incubation company Focus-X has successfully reached an acquisition agreement with Fulian Medicine

2022-12-05: https: www.cphi.cn. 2022-12-05. 16: 39. Source: PR Newswire. Author: ViaBio Focus-X Therapeutics ("Focus-X"), a nuclide drug company incubated by VivaBio, successfully entered into an acquisition agreement with Radialink Pharmaceutical Technology Co., Ltd. ("Radialink"). Focus-X Therapeutics ("Focus-X"),  


CPHI 1 month ago 1 minute read

 

Lianhua's "Qingwen" or not "Qingwen" Yiling Pharmaceutical has the final say-PR Newswire APAC

2022-12-06: On November 15, the topic of selling out even Hua Qing Zirconium capsules hit the hot search. When consumers are still waiting to see if they want to stock up, some "eye red" manufacturers have found new business opportunities, staged a "true and false beauty monkey king." Even flowers, chain flowers,  


TOUTIAO 1 month ago 1 minute read

 

Authoritative Interpretation: Omicron Mutant Strain Causes Pneumonia or Severe Disease Rate Lower Than Influenza-PR Newswire APAC

2022-12-05: According to CCTV news, recently, the topic of weakening the pathogenicity of the Omicron mutant strain has received widespread attention. The joint prevention and control mechanism of the State Council invited Tong Zhaohui, an expert in critical respiratory diseases and director of Beijing Institute


TOUTIAO 1 month ago 1 minute read

 
Lingyue Technology received Zheng Jie, the Mayor of Yuhuatai District Government of Nanjing City, for a survey and visit


MSCBSC 1 month ago 1 minute read

 

Menarini unveils latest results at SABCS 2022

2022-12-05: https: www.cphi.cn. 2022-12-05. 17: 19. Source: PR Newswire. Author: Menarini. Group Menarini Group and Stemline, a wholly owned subsidiary of Menarini Group. Therapeutics will present additional data from the experimental oral SERD drug Elacestrant Phase 3 EMERALD Study (NCT03778931) at the San  


CPHI 1 month ago 1 minute read

 

The prevention and control plan of the new coronavirus infectious disease of the Infectious Diseases Branch of the China Association of Chinese Medicine is here-PR Newswire APAC

2022-12-07: Beijing Daily client. Yao. Journalist. Bai Bo The COVID-19 pandemic has had a huge impact on human health and socio-economic development. At present, the Omicron mutant strain is mainly prevalent, its toxicity is reduced, but more contagious, resulting in an increase in the number of people with the  


TOUTIAO 1 month ago 4 minutes read

 

Academician Wu Zhaohui Appointed Vice Minister of Science and Technology, Stepping Down as President of Zhejiang University-PR Newswire APAC

2022-12-05: Wu Chaohui On December 5, the website of the Ministry of Human Resources and Social Affairs announced the appointment and dismissal of state staff by Among them, Wu was appointed vice minister of science and technology, removing Wu from his post as president of Zhejiang University. According to public


TOUTIAO 1 month ago 1 minute read

 

Experts in Chongqing and Guangzhou analyzed the local epidemic situation, and both mentioned that the virulence of Omicron was significantly weakened-PR Newswire APAC

2022-12-06: Citizens outside Zhengjia Plaza Shopping Center, Guangzhou, Guangdong Province, December 3, 2022. At present, Guangzhou all walks of life orderly resumption of work, Guangzhou Tianhe business circle passenger flow orderly recovery. Recently, the topic of the toxicity of the Omicron mutant strain of


TOUTIAO 1 month ago 1 minute read

 

Will there be a medical run? Hierarchical diagnosis and treatment plans need to be established, when to see a doctor and science popularization should be timely-PR Newswire APAC

2022-12-07: Produced by Sohu Health Author. Yu. Wu Shiyan Editorial.. Recently, several provinces and cities have adjusted the prevention and control measures of the COVID-19 epidemic, and the ninth edition of the prevention and control plan and 20 optimization measures have been implemented Among them, Hangzhou,  


TOUTIAO 1 month ago 2 minutes read

 

The price of Lianhua Qingwen and ibuprofen is several times higher than that of the hospital, and the regulatory authorities in many places have issued warnings-PR Newswire APAC

2022-12-07: China Times (www.chinatimes.net.cn) journalist. Guo Yilin. Yu Na. Beijing reporting Recently, around the "four types of drugs" purchase policy adjustment, the country blew a tide of "medicine." In the face of the price rise brought by "antimony medicine," many regulators have issued a warning. Many


TOUTIAO 1 month ago 3 minutes read

 

Imjudo combined with Infineon in the first-line treatment of unresectable liver cancer has demonstrated significant survival benefits in Hong Kong and Taiwan populations

2022-12-07: https: www.cphi.cn. 2022-12-07. 11: 20. Source: PR Newswire. Author: AstraZeneca AstraZeneca's Imjudo (generic name: tremelimumab) and Infifan (generic name: devalioximab) first-line treatment of non-resectable liver cancer in the Phase I clinical study HIMALAYA was officially announced on December  


CPHI 1 month ago 2 minutes read

 

Questions and answers on the interpretation of the "Notice on Further Optimizing and Implementing the Prevention and Control Measures of the New Coronary Pneumonia Epidemic"-PR Newswire APAC

2022-12-07: Source: National Health Commission I. What is the background of the notice? What is the main content? Since the outbreak of the new coronavirus outbreak, the Party Central Committee and the State Council have always put people's life safety and health first. According to the characteristics of virus  


TOUTIAO 1 month ago 3 minutes read

 

Nucleic acid testing in many places bid farewell to normalization: listed companies' accounts receivable surged, and more energy was devoted to routine business-PR Newswire APAC

2022-12-06: Normalized nucleic acids are saying goodbye. In recent days, China has made many adjustments to the prevention and control measures of the new coronavirus epidemic, including arrangements for nucleic acid testing, since most no longer check the negative proof of nucleic acid testing, "non-necessary  


TOUTIAO 1 month ago 1 minute read

 

Talents and equipment moved to the United States, and their own operations cannot be the masters. TSMC’s establishment of a factory in the United States has caused multiple doubts-PR Newswire APAC

2022-12-07: Source: Global Times [Global Times Special correspondent. Zhang Ruo] TSMC's plant in Phoenix, Arizona, USA, ushered in a relocation ceremony on the 6th, with key figures including US President Joe Biden attending. TSMC's opening in the United States is also believed to be the intention of the United


TOUTIAO 1 month ago 1 minute read

 

Kintor Pharmaceutical's Phase II Clinical Trial of Freetaxen in the Treatment of Female Hair Loss Achieves the Primary Endpoint

2022-12-05: https: www.cphi.cn. 2022-12-05. 14: 49. Source: PR Newswire. Author: Pioneer Pharmaceuticals On December 1, 2022, Beijing time, Kaituo Pharmaceutical (stock code: 9939.HK) announced the main results of its independent research and development and potential first-of-its-kind clinical trial in China  


CPHI 1 month ago 1 minute read

 

Making a fortune for the country? A net profit of 100 million a year! Nucleic acid gross profit is as high as 95.43 percent, how to end nucleic acid profiteering-PR Newswire APAC

2022-12-06: Marx's theory of capital says that when profits exceed 50 percent, it is enough to make capitalists crazy, let alone more than 300 percent How crazy is the profit of nucleic acid testing? According to A-share listed companies have released third-quarter results, in the nucleic acid testing concept stock,


TOUTIAO 1 month ago 1 minute read

 

"Qingke Bio" received another 400 million yuan in B-round financing, accelerating the layout of the "gene factory" construction

2022-12-06: https: www.cphi.cn. 2022-12-06. 13: 07. Source: PR Newswire. Author: Beijing Qinke Biotechnology Co., Ltd. Recently, as a powerful gene synthesis enterprise in China, Beijing Qinke Biotechnology Co., Ltd. (hereinafter referred to as "Qinke Biotech") received another 400 million yuan Recently, as  


CPHI 1 month ago 2 minutes read

 

Load More